WallStreetZenWallStreetZen

NASDAQ: OM
Outset Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for OM

Based on 3 analysts offering 12 month price targets for Outset Medical Inc.
Min Forecast
$3.00+513.5%
Avg Forecast
$4.00+718%
Max Forecast
$6.00+1,126.99%

Should I buy or sell OM stock?

Based on 3 analysts offering ratings for Outset Medical Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OM stock forecasts and price targets.

OM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-08
lockedlocked$00.00+00.00%2024-08-08
lockedlocked$00.00+00.00%2024-04-08

1 of 1

Forecast return on equity

Is OM forecast to generate an efficient return?
Company
N/A
Industry
25.44%
Market
58.96%

Forecast return on assets

Is OM forecast to generate an efficient return on assets?
Company
N/A
Industry
13.61%

OM earnings per share forecast

What is OM's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$2.52
Avg 2 year Forecast
-$1.91
Avg 3 year Forecast
-$1.45

OM revenue forecast

What is OM's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$110.4M-5.16%
Avg 2 year Forecast
$123.3M+5.92%
Avg 3 year Forecast
$161.5M+38.7%
OM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OM revenue growth forecast

How is OM forecast to perform vs Medical Devices companies and vs the US market?
Company
10.28%
Industry
7.1%
Market
9.31%
OM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
OM$0.49$4.00+718.00%Strong Buy
NMTC$0.79N/AN/A
LFWD$3.09$13.00+320.71%Buy
MDAI$1.34$4.75+254.48%Buy
MOVE$0.31$2.00+543.09%Buy

Outset Medical Stock Forecast FAQ

Is Outset Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: OM) stock is to Strong Buy OM stock.

Out of 3 analysts, 2 (66.67%) are recommending OM as a Strong Buy, 0 (0%) are recommending OM as a Buy, 1 (33.33%) are recommending OM as a Hold, 0 (0%) are recommending OM as a Sell, and 0 (0%) are recommending OM as a Strong Sell.

If you're new to stock investing, here's how to buy Outset Medical stock.

What is OM's earnings growth forecast for 2024-2026?

(NASDAQ: OM) Outset Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 27.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Outset Medical's earnings in 2024 is -$159,178,000.On average, 4 Wall Street analysts forecast OM's earnings for 2024 to be -$131,266,283, with the lowest OM earnings forecast at -$137,517,059, and the highest OM earnings forecast at -$121,369,222. On average, 4 Wall Street analysts forecast OM's earnings for 2025 to be -$99,491,508, with the lowest OM earnings forecast at -$105,221,386, and the highest OM earnings forecast at -$85,948,162.

In 2026, OM is forecast to generate -$75,530,203 in earnings, with the lowest earnings forecast at -$75,530,203 and the highest earnings forecast at -$75,530,203.

What is OM's revenue growth forecast for 2024-2026?

(NASDAQ: OM) Outset Medical's forecast annual revenue growth rate of 10.28% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.31%.

Outset Medical's revenue in 2024 is $116,425,000.On average, 4 Wall Street analysts forecast OM's revenue for 2024 to be $5,751,338,446, with the lowest OM revenue forecast at $5,730,919,246, and the highest OM revenue forecast at $5,781,967,245. On average, 4 Wall Street analysts forecast OM's revenue for 2025 to be $6,423,713,519, with the lowest OM revenue forecast at $6,198,685,605, and the highest OM revenue forecast at $6,719,583,555.

In 2026, OM is forecast to generate $8,411,460,097 in revenue, with the lowest revenue forecast at $6,987,325,101 and the highest revenue forecast at $11,110,753,274.

What is OM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OM) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 13.61%.

What is OM's Price Target?

According to 3 Wall Street analysts that have issued a 1 year OM price target, the average OM price target is $4.00, with the highest OM stock price forecast at $6.00 and the lowest OM stock price forecast at $3.00.

On average, Wall Street analysts predict that Outset Medical's share price could reach $4.00 by Aug 8, 2025. The average Outset Medical stock price prediction forecasts a potential upside of 718% from the current OM share price of $0.49.

What is OM's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: OM) Outset Medical's current Earnings Per Share (EPS) is -$3.13. On average, analysts forecast that OM's EPS will be -$2.52 for 2024, with the lowest EPS forecast at -$2.64, and the highest EPS forecast at -$2.33. On average, analysts forecast that OM's EPS will be -$1.91 for 2025, with the lowest EPS forecast at -$2.02, and the highest EPS forecast at -$1.65. In 2026, OM's EPS is forecast to hit -$1.45 (min: -$1.45, max: -$1.45).

What is OM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.